Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3: July 23 to 24, 1992, Portland, Oregon
Gespeichert in:
Körperschaft: | |
---|---|
Format: | Tagungsbericht Buch |
Sprache: | English |
Veröffentlicht: |
Norwalk, CT
Appleton & Lange
1993
|
Schriftenreihe: | Transplantation proceedings
25,2 : Supplement 1 |
Schlagworte: | |
Beschreibung: | Literaturangaben |
Beschreibung: | 93 S. Ill., graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV008224786 | ||
003 | DE-604 | ||
005 | 19930921 | ||
007 | t | ||
008 | 930921s1993 ad|| |||| 10||| eng d | ||
035 | |a (OCoLC)30329932 | ||
035 | |a (DE-599)BVBBV008224786 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-12 | ||
050 | 0 | |a QR188.8 | |
111 | 2 | |a International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 |d 1992 |c Portland, Or. |j Verfasser |0 (DE-588)3017272-X |4 aut | |
245 | 1 | 0 | |a Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 |b July 23 to 24, 1992, Portland, Oregon |c guest ed. Douglas J. Norman |
246 | 1 | 3 | |a Clinical and basic science perspectives on the use of OKT3 |
264 | 1 | |a Norwalk, CT |b Appleton & Lange |c 1993 | |
300 | |a 93 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Transplantation proceedings |v 25,2 : Supplement |v 1 | |
500 | |a Literaturangaben | ||
650 | 2 | |a Immunologie en transplantation - action des médicaments et substances chimiques - Congrès comme sujet | |
650 | 2 | |a Muromonab-CD3 - usage thérapeutique - Congrès comme sujet | |
650 | 4 | |a Portland, Oregon - 1992 | |
650 | 4 | |a Immunosuppressive agents |x Therapeutic use |v Congresses | |
650 | 4 | |a Monoclonal antibodies |x Therapeutic use |v Congresses | |
650 | 4 | |a Transplantation immunology |v Congresses | |
650 | 4 | |a Transplantation of organs, tissues, etc. |v Congresses | |
650 | 0 | 7 | |a OKT 3 |0 (DE-588)4215963-5 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1992 |z Portland Or. |2 gnd-content | |
689 | 0 | 0 | |a OKT 3 |0 (DE-588)4215963-5 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Norman, Douglas J. |e Sonstige |4 oth | |
999 | |a oai:aleph.bib-bvb.de:BVB01-005428193 |
Datensatz im Suchindex
_version_ | 1804122610731057152 |
---|---|
any_adam_object | |
author_corporate | International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 Portland, Or |
author_corporate_role | aut |
author_facet | International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 Portland, Or |
author_sort | International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 Portland, Or |
building | Verbundindex |
bvnumber | BV008224786 |
callnumber-first | Q - Science |
callnumber-label | QR188 |
callnumber-raw | QR188.8 |
callnumber-search | QR188.8 |
callnumber-sort | QR 3188.8 |
callnumber-subject | QR - Microbiology |
ctrlnum | (OCoLC)30329932 (DE-599)BVBBV008224786 |
format | Conference Proceeding Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01860nam a2200433 cb4500</leader><controlfield tag="001">BV008224786</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19930921 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930921s1993 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)30329932</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008224786</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR188.8</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3</subfield><subfield code="d">1992</subfield><subfield code="c">Portland, Or.</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)3017272-X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3</subfield><subfield code="b">July 23 to 24, 1992, Portland, Oregon</subfield><subfield code="c">guest ed. Douglas J. Norman</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Clinical and basic science perspectives on the use of OKT3</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Norwalk, CT</subfield><subfield code="b">Appleton & Lange</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">93 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Transplantation proceedings</subfield><subfield code="v">25,2 : Supplement</subfield><subfield code="v">1</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Immunologie en transplantation - action des médicaments et substances chimiques - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Muromonab-CD3 - usage thérapeutique - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Portland, Oregon - 1992</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunosuppressive agents</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Monoclonal antibodies</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplantation immunology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplantation of organs, tissues, etc.</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">OKT 3</subfield><subfield code="0">(DE-588)4215963-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1992</subfield><subfield code="z">Portland Or.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">OKT 3</subfield><subfield code="0">(DE-588)4215963-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Norman, Douglas J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005428193</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1992 Portland Or. gnd-content |
genre_facet | Konferenzschrift 1992 Portland Or. |
id | DE-604.BV008224786 |
illustrated | Illustrated |
indexdate | 2024-07-09T17:16:37Z |
institution | BVB |
institution_GND | (DE-588)3017272-X |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005428193 |
oclc_num | 30329932 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-12 |
owner_facet | DE-19 DE-BY-UBM DE-12 |
physical | 93 S. Ill., graph. Darst. |
publishDate | 1993 |
publishDateSearch | 1993 |
publishDateSort | 1993 |
publisher | Appleton & Lange |
record_format | marc |
series2 | Transplantation proceedings |
spelling | International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 1992 Portland, Or. Verfasser (DE-588)3017272-X aut Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 July 23 to 24, 1992, Portland, Oregon guest ed. Douglas J. Norman Clinical and basic science perspectives on the use of OKT3 Norwalk, CT Appleton & Lange 1993 93 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Transplantation proceedings 25,2 : Supplement 1 Literaturangaben Immunologie en transplantation - action des médicaments et substances chimiques - Congrès comme sujet Muromonab-CD3 - usage thérapeutique - Congrès comme sujet Portland, Oregon - 1992 Immunosuppressive agents Therapeutic use Congresses Monoclonal antibodies Therapeutic use Congresses Transplantation immunology Congresses Transplantation of organs, tissues, etc. Congresses OKT 3 (DE-588)4215963-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1992 Portland Or. gnd-content OKT 3 (DE-588)4215963-5 s DE-604 Norman, Douglas J. Sonstige oth |
spellingShingle | Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 July 23 to 24, 1992, Portland, Oregon Immunologie en transplantation - action des médicaments et substances chimiques - Congrès comme sujet Muromonab-CD3 - usage thérapeutique - Congrès comme sujet Portland, Oregon - 1992 Immunosuppressive agents Therapeutic use Congresses Monoclonal antibodies Therapeutic use Congresses Transplantation immunology Congresses Transplantation of organs, tissues, etc. Congresses OKT 3 (DE-588)4215963-5 gnd |
subject_GND | (DE-588)4215963-5 (DE-588)1071861417 |
title | Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 July 23 to 24, 1992, Portland, Oregon |
title_alt | Clinical and basic science perspectives on the use of OKT3 |
title_auth | Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 July 23 to 24, 1992, Portland, Oregon |
title_exact_search | Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 July 23 to 24, 1992, Portland, Oregon |
title_full | Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 July 23 to 24, 1992, Portland, Oregon guest ed. Douglas J. Norman |
title_fullStr | Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 July 23 to 24, 1992, Portland, Oregon guest ed. Douglas J. Norman |
title_full_unstemmed | Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 July 23 to 24, 1992, Portland, Oregon guest ed. Douglas J. Norman |
title_short | Proceedings of an International Symposium on Clinical and Basic Science Perspectives on the Use of OKT3 |
title_sort | proceedings of an international symposium on clinical and basic science perspectives on the use of okt3 july 23 to 24 1992 portland oregon |
title_sub | July 23 to 24, 1992, Portland, Oregon |
topic | Immunologie en transplantation - action des médicaments et substances chimiques - Congrès comme sujet Muromonab-CD3 - usage thérapeutique - Congrès comme sujet Portland, Oregon - 1992 Immunosuppressive agents Therapeutic use Congresses Monoclonal antibodies Therapeutic use Congresses Transplantation immunology Congresses Transplantation of organs, tissues, etc. Congresses OKT 3 (DE-588)4215963-5 gnd |
topic_facet | Immunologie en transplantation - action des médicaments et substances chimiques - Congrès comme sujet Muromonab-CD3 - usage thérapeutique - Congrès comme sujet Portland, Oregon - 1992 Immunosuppressive agents Therapeutic use Congresses Monoclonal antibodies Therapeutic use Congresses Transplantation immunology Congresses Transplantation of organs, tissues, etc. Congresses OKT 3 Konferenzschrift 1992 Portland Or. |
work_keys_str_mv | AT internationalsymposiumonclinicalandbasicscienceperspectivesontheuseofokt3portlandor proceedingsofaninternationalsymposiumonclinicalandbasicscienceperspectivesontheuseofokt3july23to241992portlandoregon AT normandouglasj proceedingsofaninternationalsymposiumonclinicalandbasicscienceperspectivesontheuseofokt3july23to241992portlandoregon AT internationalsymposiumonclinicalandbasicscienceperspectivesontheuseofokt3portlandor clinicalandbasicscienceperspectivesontheuseofokt3 AT normandouglasj clinicalandbasicscienceperspectivesontheuseofokt3 |